Показати скорочений опис матеріалу
dc.contributor.author | Bidnyuk, V. K. | en |
dc.contributor.author | Pervak, M. P. | en |
dc.contributor.author | Poshyvak, O. B. | en |
dc.contributor.author | Yehorenko, O. S. | en |
dc.contributor.author | Varava, S. V. | en |
dc.contributor.author | Godlevsky, L. S. | en |
dc.contributor.author | Haustov, O. O. | en |
dc.date.accessioned | 2022-12-09T08:45:29Z | |
dc.date.available | 2022-12-09T08:45:29Z | |
dc.date.issued | 2022 | |
dc.identifier.citation | Pentylenetetrazole-induced kindling as a model metabolic syndrome / V. K., Bidnyuk, M. P. Pervak, O. B. Poshyvak et al // Acta neurobiologia experimentalis: II 12th Neuronus 2022 Neuroscience Forum, 15–17 october 2022, Krakov, Poland. Vol. 82. P. 95. | en |
dc.identifier.uri | https://repo.odmu.edu.ua:443/xmlui/handle/123456789/11715 | |
dc.description.abstract | Data on the relationship between epilepsy and metabolic syndrome justified the evaluation of MS markers expression in PTZ-kindled rats. PTZ kindling was induced in four months aged male Wistar rats with three weeks epileptogen (35.0 mg/kg, i.p.) administration. Those animals with fully developed generalized seizures were used for investigations. The glucose tolerance test (GTT) was followed by a significant rising in blood glucose level 30 min after glucose i.p. administration (2.0 g/kg) up to 395.7+47.2 mg/dl), which exceeded the control data by 1.74 times (P<0.001). Insulin tolerance test (0.75 U of insulin/kg) revealed in 15 min after glucose i.p. administration (2.0 g/kg) up to 114.3+15.7 mg/dl), which exceed the control data by 31.3% (P<0.001). | en |
dc.language.iso | en | en |
dc.subject | Pentylenetetrazole-induced kindling | en |
dc.subject | model metabolic syndrome | en |
dc.subject | epilepsy | en |
dc.subject | Insulin tolerance test | en |
dc.title | Pentylenetetrazole-induced kindling as a model metabolic syndrome | en |
dc.type | Article | en |